Adagrasib,Cetuximab,Afatinib,Pembrolizumab
Mirati,Eli Lilly,Boehringer Ingelheim,Merck
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
great summary and thought provoking discussion by on crc clinical trials presented this #esmo22 
Clinical Oncologist.
Fellow at European School of Oncology @ESOncology. Proud Kilifornian